Full text
Earnings transcript
Read the complete earnings call transcript.
ASPI
ASP Isotopes Inc. Common Stock
$4.29
0.18
(4.38%)
[ms_data_label text=’Delayed data’]
| Exchange: | NASDAQ |
| Market Cap: | 400.714M |
| Shares Outstanding: | 34.357M |
About The Company
| Sector: | Basic Materials | |||||
| Industry: | Chemicals | |||||
| CEO: | Paul Elliot Mann | |||||
| Full Time Employees: | 136 | |||||
| Address: |
| |||||
| Website: | aspisotopes.com |
ASP Isotopes Inc., a pre-commercial stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It develops Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company also Uranium-235, an isotope of uranium for carbon-free energy industry. ASP Isotopes Inc. was incorporated in 2021 and is based in Boca Raton, Florida.
Click to read more…
Revenue Segmentation
EPS
Historical EPS and analyst estimates in one chart. Log in for the full interactive view and links to detailed estimates.
Earnings Call
AI summary
Key takeaways
Short, structured highlights from the call so you can focus on what matters.
Log in to continue
Log in to read the full transcript and AI-generated earnings summaries.
Login — it's freeIncome Statement
| Year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | 433.026 | 4,144 | 23,849 |
| Gross Profit | 138.970 | 1,599 | 3,405 |
| EBITDA | -16,144.279 | -31,582 | -157,074 |
| Operating Income | -16,041.999 | -26,354 | -57,191 |
| Net Income | -16,286.234 | -32,334 | -175,092 |
(* All numbers are in thousands)
Balance Sheet
| Year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Total Assets | 30,187.299 | 94,347.988 | 512,881.999 |
| Total Liabilities | 11,356.668 | 43,181.548 | 249,984 |
| Total Stockholders Equity | 16,295.953 | 47,898.492 | 204,151 |
| Total Debt | 2,142.640 | 37,745.925 | 215,960 |
| Cash and Cash Equivalents | 7,908.181 | 61,890.048 | 285,563 |
(* All numbers are in thousands)
Cash Flow Statement
| Year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Operating Cash Flow | -5,412.392 | -16,695.364 | -37,780 |
| Capital Expenditure | -2,331.343 | -11,372.395 | -9,654 |
| Free Cash Flow | -7,743.735 | -28,067.764 | -47,434 |
| Net Income | -16,294.126 | -32,422.728 | -175,092 |
| Net Change in Cash | 5,519.041 | 53,981.867 | 223,672.952 |
(* All numbers are in thousands)
Analyst Estimates
| Fiscal Year | 2030 | Full Access | Full Access | Full Access | Full Access |
|---|---|---|---|---|---|
| Estimated Revenue (Low) | 600,022.037 | Full Access | Full Access | Full Access | Full Access |
| Estimated Revenue (High) | 799,878.886 | Full Access | Full Access | Full Access | Full Access |
| Estimated Revenue (Avg) | 721,124.325 | Full Access | Full Access | Full Access | Full Access |
| Estimated Ebitda (Low) | -159,975.777 | Full Access | Full Access | Full Access | Full Access |
| Estimated Ebitda (High) | -120,004.407 | Full Access | Full Access | Full Access | Full Access |
| Estimated Ebitda (Avg) | -144,224.864 | Full Access | Full Access | Full Access | Full Access |
| Estimated Net Income (Low) | 34,391.702 | Full Access | Full Access | Full Access | Full Access |
| Estimated Net Income (High) | 50,243.978 | Full Access | Full Access | Full Access | Full Access |
| Estimated Net Income (Avg) | 43,997.205 | Full Access | Full Access | Full Access | Full Access |
| Estimated SGA Expense (Low) | 5,473,653.813 | Full Access | Full Access | Full Access | Full Access |
| Estimated SGA Expense (High) | 7,296,832.190 | Full Access | Full Access | Full Access | Full Access |
| Estimated SGA Expense (Avg) | 6,578,399.905 | Full Access | Full Access | Full Access | Full Access |
| Estimated EPS (Avg) | 0.530 | Full Access | Full Access | Full Access | Full Access |
| Estimated EPS (High) | 0.610 | Full Access | Full Access | Full Access | Full Access |
| Estimated EPS (Low) | 0.410 | Full Access | Full Access | Full Access | Full Access |
| Number of Analysts (Estimated Revenue) | 1 | Full Access | Full Access | Full Access | Full Access |
| Number of Analysts (Estimated EPS) | 1 | Full Access | Full Access | Full Access | Full Access |
Log in to continue
Log in and subscribe to Full Access to see up to 5 years of analyst estimates.
Login — it's free(* All numbers are in thousands)
Current Key Metrics
Log in to continue
Log in to see all key valuation metrics and ratios for this symbol.
Login — it's freeForward P/E Ratios
Log in to continue
Log in with Full Access for forward P/E high/low estimates and the full multi-year table.
Login — it's freeSWOT Analysis
Strengths (preview)
- Robust Financial Performance: ASPI demonstrates consistent revenue growth as reflected in the Income Statements, with positive trends in net income and operating cash flow from the Cash Flow Statements. This indicates strong operational efficiency and financial health.
- Favorable Valuation Metrics: The current price-to-earnings ratio (P/E TTM) and forward P/E ratios suggest that ASPI is reasonably valued compared to industry averages (from Industry and Sector data), potentially indicating an attractive investment relative to peers.
- Strong Market Position: ASPI’s market capitalization and position within its sector (from Company Profile) highlight a competitive standing, supported by a stable gross profit margin (Key Metrics) that reflects effective cost management.
Log in with Full Access for Weaknesses, Opportunities, Threats, and the complete SWOT.
At what price to buy it? -
Intrinsic Value Calculator
This is an automatic estimate. The most reliable way to know fair value for your own assumptions is to run the calculator below.
Common questions about ASPI valuation
Is ASP Isotopes Inc. Common Stock (ASPI) overvalued or undervalued right now?
MARKETSnap estimates intrinsic value for ASP Isotopes Inc. Common Stock (ASPI) using its proprietary valuation methodology, which incorporates discounted cash flow (DCF) analysis together with long-term earnings and fundamentals assumptions. By comparing intrinsic value to the current market price, long-term investors can see whether the stock screens as potentially overvalued, fairly valued, or undervalued today.
Is ASPI a buy, hold, or sell for long-term investors?
MARKETSnap does not give one-word “buy” or “sell” calls. Instead, it shows whether ASPI trades at a premium or discount to its estimated intrinsic value, how sensitive that value is to growth and margin assumptions, and how the stock fits into a diversified, long-term portfolio so investors can make their own buy, hold, or sell decision.
What is ASPI’s P/E ratio?
You can see ASPI’s trailing P/E (TTM) and forward P/E estimates in the Current Key Metrics and Forward P/E Ratios sections above. The P/E ratio compares the current share price to earnings per share and helps investors gauge valuation relative to earnings.
How is intrinsic value calculated for ASPI?
MARKETSnap uses its own valuation framework—not a generic spreadsheet DCF alone. Future cash flows and earnings are projected, discounted, and combined with MARKETSnap’s methodology so intrinsic value reflects fundamentals and long-term assumptions. You can run your own inputs and see the result using the Intrinsic Value Calculator above.
Is ASPI a good long-term investment?
Whether ASPI fits a long-term portfolio depends on your assumptions about growth, margins, and risk. MARKETSnap provides the metrics, intrinsic value calculator, and SWOT context so you can form your own view rather than rely on a single buy/sell rating.
ASPI
1-day price chart preview. Log in for 1W through 5Y ranges and period tabs.
[ms_data_label text="Daily snapshot"]
4.38
Trading Metrics:
| Open: | [ms_cell_or_dash table='trading_quote' column='open'] | Previous Close: | [ms_cell_or_dash table='trading_quote' column='previousClose'] | |
| Day Low: | [ms_cell_or_dash table='trading_quote' column='dayLow'] | Day High: | [ms_cell_or_dash table='trading_quote' column='dayHigh'] | |
| Year Low: | 3.92 | Year High: | 14.49 | |
| Price Avg 50: | 5.57 | Price Avg 200: | 7.68 | |
| Volume: | 3.093M | Average Volume: | 4.704M |
Log in to continue
Log in for multi-period charts (1W–5Y), period tabs, and the same layout as members.
Login — it's freeASPI full analysis
Welcome to MARKETSNAP’s SWOT analysis for Aspire Mining Limited, ticker ASPI. If you’re a long-term investor looking to dig into the potential of this company, you’ve come to the right place. Today, we’re breaking down the strengths, weaknesses, opportunities, and threats surrounding Aspire Mining, a player in the mining sector with a focus on coal exploration and development, primarily in Mongolia. Let’s unpack what’s going on with this company, look at the latest developments, and figure out if it’s a…
